Similarly, AML can be dependent on SWI/SNF subunits, BRG1, BRD4, and BRD9, all components of GBAF, and exhibit sensitivity to BRD9 inhibition [300,301,302]. Here, BRD9 is linked to acute myeloid leukemia.